Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIA2 | P42262 | 6/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15730102 | 0.78 | LMNA (0.36) | GRIA2CYP2C9CYP1A2CYP2C19LMNA | |
| SCHEMBL20365092 | 0.77 | LMNA (0.33) | GRIA2CYP2C9CYP1A2CYP2C19LMNA | |
| SCHEMBL17066945 | 0.74 | LMNA (0.40) | GRIA2CYP2C9CYP1A2CYP2C19LMNA | |
| SCHEMBL15730088 | 0.69 | LMNA (0.33) | LMNATSHRNPSR1GAATDP1 | |
| SCHEMBL15724387 | 0.68 | RXRA (0.31) | LMNA | |
| SCHEMBL15730339 | 0.66 | LMNA (0.33) | LMNATSHRNPSR1GAATDP1 | |
| SCHEMBL15723783 | 0.66 | LMNA (0.31) | GRIA2CYP2C9CYP1A2LMNATSHR | |
| SCHEMBL15724381 | 0.65 | HTR2A (0.30) | — | |
| SCHEMBL18854109 | 0.60 | HTR2A (0.32) | — | |
| SCHEMBL15730598 | 0.60 | LMNA (0.36) | LMNATSHRNPSR1GAATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013006738-A1 | COMPOUNDS FOR THE TREATMENT OF HIV | GILEAD SCIENCES, INC. (US) | 2013-01-10 | — | — | WO | disclosed |